Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer

Published:2006-12-02 Issue:3 Volume:60 Page:321-328
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Hong Yong Sang,Lee Jeeyun,Lee Sang Cheol,Hwang In Gyu,Choi Seong-Ho,Heo Jin-Seok,Park Joon Oh,Park Young Suk,Lim Ho Yeong,Kang Won Ki

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-006-0380-9.pdf

Reference39 articles.

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ (2003) Cancer statistics. CA Cancer J Clin 53:5–26

2. Patel T (2002) Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2:10

3. Faivre J, Forman D, Esteve J, Obradovic M, Sant M (1998) Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe. EUROCARE Working Group. Eur J Cancer 34:2184–2190

4. Shin HRJK, Won YJ, Park JG, 139 KCCR-affiliated Hospitals (2004) 2002 annual report of the Korea Central Cancer Registry. Cancer Res Treat 36:103–114

5. Hirono S, Tani M, Kawai M, Ina S, Uchiyama K, Yamaue H (2006) Indication of hepatopancreatoduodenectomy for biliary tract cancer (discussion 574–565). World J Surg 30:567–573

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Status and Progress of Systemic and Local Therapy for Intrahepatic Cholangiocarcinoma;Advances in Clinical Medicine;2024

2. Identification of Novel Ribonucleotide Reductase Inhibitors for Therapeutic Application in Bile Tract Cancer: An Advanced Pharmacoinformatics Study;Biomolecules;2022-09-10

3. Novel Palliative Chemotherapy for Cholangiocarcinoma;The Korean Journal of Pancreas and Biliary Tract;2022-04-30

4. Chemotherapy for advanced gallbladder cancer (GBC): A systematic review and meta-analysis;Critical Reviews in Oncology/Hematology;2021-07

5. Comparison between Fluoropyrimidine-Cisplatin and Gemcitabine-Cisplatin as First-Line Chemotherapy for Advanced Biliary Tract Cancer: A Meta-Analysis;Oncology Research and Treatment;2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3